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 A high index of suspicion for arrhythmogenic right
ventricular cardiomyopathy is necessary even if
Task Force Criteria are not initially met, and one
should recognize that right ventricle repolarization
abnormalities are not always ﬁxed during the
disease course.
 Extensive epicardial electrophysiological
abnormalities can be present in the absence of
endocardial correlates and pathology seen
noninvasively with cardiac magnetic resonance
imaging and echocardiography.Introduction
We present a case involving an initially unsuccessful ablation
attempt of a right ventricular outﬂow tract (RVOT) ventricu-
lar tachycardia (VT) and the subsequent management that
provided a deﬁnitive diagnosis and effective treatment. VT
with left bundle branch block morphology and an inferior
axis is often caused by focal tachycardia arising from the
RVOT. The differential for this arrhythmia includes a macro-
reentrant VT. This can be due to arrhythmogenic right ven-
tricular cardiomyopathy (ARVC),1 which is diagnosed
using a combination of clinical cues and electrical and nonin-
vasive imaging to meet the Task Force Criteria.2 This case
demonstrates the difﬁculties with diagnosis in the early sub-
clinical phase of ARVC and illustrates the pathophysiology
of reentrant VT.  Reentrant circuits can be fully delineated with
detailed multipolar mapping.
 A failed endocardial approach should warrant early
consideration of epicardial access.Case report
A 24-year-old woman was referred to a tertiary cardiac center
with recurrent, hemodynamically tolerated broad complex
tachycardia, consistent with RVOT-VT. She had been hospi-
talized on 10 occasions for symptomatic palpitations in the
preceding 3 months, having undergone several direct current
cardioversions. There was no family history of premature
sudden cardiac death.
Prior investigations included a normal echocardiogram
and 12-lead electrocardiogram (ECG). Cardiac magnetic
resonance imaging (CMR) was normal with the exception
of minor irregularities in the free wall of the right ventricle
(RV). A 24-hour Holter recording revealed a high burden
of ventricular ectopy (VE), which correlated with patient
symptoms. A trial of medical therapy was undertaken,
initially with bisoprolol, then concomitantly with diltiazem
and subsequently sotalol monotherapy.
Previous elective catheter ablation of the VEs and RVOT
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(CARTO v3, Johnson & Johnson, New Brunswick, NJ).
For both cases, the origin was mapped to the RVOT and abla-
tion during VT terminated the tachycardia. On the second
occasion programmed electrical stimulation was performed
at the end of the case, but the clinical VT was still inducible.
Of note, neither endocardial scar nor a diastolic pathway was
seen during either study. The patient had further episodes of
tachycardia and was referred to our center.
Given the frequency of her tachycardia, she was admitted
from clinic and treatment with ﬂecainide was initiated. Her
12-lead ECGs showed T-wave inversion (TWI) in V1–V3,
which contrasted with normal T wave on prior ECGs. An
exercise ECG demonstrated VT with similar morphology
to the previous clinical events, with a slightly slower rate.
The repolarization changes seen on the 12-lead ECG and
the resistance of the arrhythmia to endocardial ablation
prompted a reevaluation of the diagnosis. An electrophysi-
ology study was scheduled with a high index of suspicion
for an arrhythmogenic cardiomyopathy, given the borderlineen access article
.0/).
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Figure 1 A: Left lateral unipolar voltage map of right ventricle endocardium. B: Left lateral view of the endocardial activation map during ventricular tachy-
cardia (VT). Ablation lesions are displayed on the right ventricular outﬂow tract septumwith earliest activation in red. Note the diffuse endocardial early activation
indicative of an epicardial-to-endocardial breakthrough.C: Intracardiac electrograms with surface electrocardiogram (ECG) showing broad complex tachycardia
with left bundle branch block (LBBB) morphology with an inferior axis.D:A 12-lead surface ECG of VT on admission showing the same LBBB and inferior axis
as during the case. RVOT 5 right ventricular outﬂow tract.
2 Heart Rhythm Case Reports, Vol-, No-,- 2019diagnosis comprised of 1 major (12-lead ECG TWI) and 1
minor criteria (VT with inferior axis).
VT was easily inducible at the start of the procedure with a
600-ms drive and S2 at 320 ms from the RV apex. The VT
was consistent with the clinical VT previously demonstrated
(Figure 1D). The case was performed with 3D mapping
(CARTO v3). The RV endocardium was mapped using a de-
capolar catheter with the site of earliest activation in the
septal portion of the RVOT, with no diastolic electrograms
seen (Figure 1). Entrainment was performed with a postpac-
ing interval of 26 ms (Figure 1C). Ablation in this area termi-
nated VT after 20 seconds of radiofrequency (RF) energy
delivery. Further consolidative adjacent lesions were deliv-
ered. Reinduction of broad complex tachycardia was possible
using a 600-ms drive with S2 at 320 ms and S3 at 300 ms.
A decision was made to perform epicardial access and
mapping; this was achieved via a subxiphisternal approach.
VT spontaneously terminated during epicardial access.
Figure 2A shows a sinus rhythm voltage map of the
epicardial surface created using the decapolar catheter andthe fractionated electrograms that are often seen in ARVC
cases (Figure 2C).3 Figure 2B shows the 12-lead ECG during
sinus rhythm with T-wave inversion in leads V1–V3. VT was
reinduced with the aforementioned induction protocol and
the entire diastolic pathway mapped with the decapolar cath-
eter, as illustrated in Figure 3B. Figure 3A shows the activa-
tion map during VT.
Entrainment was attempted in the diastolic pathway;
however, myocardial capture was not possible despite
maximum output. Ablation in this region resulted in immedi-
ate termination of this tachycardia (Figure 3C). Further le-
sions were applied to this area and no further VT was
inducible despite a fullWellens protocol. The patient was dis-
charged on bisoprolol and has reported no further symptoms
on follow-up in clinic 3 months post ablation.Discussion
This case illustrates key principles for management of VT in
ARVC. The reentrant mechanism of scar-related VT, along
Figure 2 A: Epicardial bipolar voltage map created during sinus rhythm (SR), with bipolar voltage setting at 0.5 mV to 1.5 mV. Maps are displayed in right
anterior oblique (RAO), anterior posterior (AP), and left anterior oblique (LAO) from left to right. B: Resting 12-lead electrocardiogram showing T-wave inver-
sion in V1–V3. C: Late and fractionated potentials seen recorded epicardially from the decapolar catheter during SR.
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has been well described.4 However, it is rare to see this sub-
strate clearly demonstrated in the intact human heart—espe-
cially given that the majority of VT induced during catheter
ablation is unstable5—although with advances in electroana-
tomic mapping systems and the tools utilized, it is hoped that
it will become more commonplace.6
The alignment of the decapolar catheter allowed us to
anatomically demarcate the entire isthmus from its entrance,
represented by the local electrograms on electrode poles 9–10
of the decapolar catheter (Figure 3B), to the exit site seen later
in diastole on poles 3–4. The signal on 1–2 represents the far-
ﬁeld signal from global ventricular activation, with poten-
tially a small near-ﬁeld component at the onset of the far-
ﬁeld electrogram. Unfortunately, entrainment was not
possible owing to lack of capture of the tissue underlying
the catheter. This lack of capture is a common problem
encountered when attempting to pace from scarred areas7
and areas of epicardial fat.8
Further evidence that this site represents an essential
component of the VT circuit is provided by the termina-
tion with epicardial ablation and the subsequent nonindu-cibility of the tachycardia. Interestingly, termination also
occurred during endocardial ablation. This could be on
account of the RV wall being thin, leading to delivery
of RF energy endocardially causing edema epicardially,
or owing to endocardial components of the circuit being
affected.8
Endo 1 epicardial vs endocardial-only VT ablation for
ARVC has been shown to improve outcomes.9 The diag-
nostic uncertainty that exists in cases such as this can delay
attempts at potentially curative epicardial ablation and the
implantation of an implantable cardioverter-deﬁbrillator.
The repolarization abnormalities detected on her 12-lead
ECG on presentation at our center was a key factor in high-
lighting an ARVC diagnosis. TWI in the RV precordial leads
has been shown to accurately differentiate ARVC from
RVOT VT in the normal heart.10 The fact that TWI was
absent in the index ECGs made the diagnosis more difﬁcult.
Repolarization abnormalities can be transient and change
over time in ARVC; hence multiple ECGs over time should
be reviewed in suspected cases.11 Additionally, in cases of
diagnostic uncertainty an endomyocardial biopsy can be
considered as a tool to conﬁrm the diagnosis.12
Figure 3 A: Anteroposterior view of activation map of ventricular tachycardia (VT) superimposed onto full epicardial geometry for orientation. Early and late
activation are displayed in red and blue, respectively. The area of early activation shows the diastolic activation from the isthmus of the VT circuit. B: Surface
electrocardiogram leads and epicardial bipolar electrograms recorded from a decapolar catheter on the isthmus during VT. Entrance to the isthmus can be seen on
poles 9–10, with diastolic electrograms seen on subsequent poles following the pathway to the exit on 1–2. RVA catheter recordings are from the right ventricular
apex. C: Termination within a few seconds of ablation on the area marked with Visitags on A.
4 Heart Rhythm Case Reports, Vol-, No-,- 2019In conclusion, this case demonstrates the distinct compo-
nents of the epicardial VT circuit present in a patient with
previously undiagnosed ARVC and clearly illustrates the
important role of an epicardial ablation approach to deﬁne
the substrate.References
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